Clostridium difficile is the major aetiological agent of antibiotic associated diarrhoea and
colitis. The majority of hospitalized patients infected by C. difficile are asymptomatic carriers …

Background There is increasing concern about the apparently rising incidence and
worsening outcome of Clostridium difficile infection (CDI) associated with inflammatory …

AIM To address the management of Clostridium difficile (C. difficile) infection (CDI) in the
setting of suspected inflammatory bowel disease (IBD)-flare. METHODS A systematic search …

Clostridium difficile-associated disease (CDAD) with frequent watery stools, sometimes with
painful bowel movements, fever and sickness, is probably the major known cause of …

There is rising incidence and prevalence of inflammatory bowel disease (IBD) in India
topping the Southeast Asian (SEA) countries. The common genes implicated in disease …

Clostridioides difficile (C. difficile) is the most common pathogen causing antibiotic-
associated intestinal diseases in humans and some animal species, but it can also be …

There is resurgent interest in the use of probiotics to maintain gastrointestinal and systemic
health, driven by recent advances in knowledge of bacterial interactions with the epithelium …

Inflammatory bowel diseases (IBD) affect millions of people worldwide with increasing
incidence. Ulcerative colitis (UC) and Crohn's disease (CD) are the two most common IBDs …

The spectrum of Clostridium difficile-associated diarrhea (CDAD) is changing. Apart from
antibiotic use, other risk factors such as use of proton pump inhibitors (PPI) and …

Objective To describe the impact and epidemiology of Clostridium difficile infection (CDI) in
low‐and middle‐human development index (LMHDI) countries. Method Prospectively …